Treatment for Autoimmune Diseases

Phase-Based Progress Estimates
Personalized Lifestyle Medicine Center, Gig Harbor, WA
Autoimmune Diseases+9 More
All Sexes
Eligible conditions

Study Summary

This study is evaluating whether a personalized lifestyle intervention program can improve functional capacity.

See full description

Eligible Conditions

  • Autoimmune Diseases
  • Health, Subjective
  • Cardiovascular Risk
  • Hormone Disturbance
  • Neurocognitive Dysfunction
  • Gastrointestinal Dysfunction
  • Dental Diseases

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Treatment will improve 3 primary outcomes and 18 secondary outcomes in patients with Autoimmune Diseases. Measurement will happen over the course of Change from baseline at 12 months.

Month 12
25-hydroxy (OH) Vitamin D3
Anti-Nuclear Antibodies (ANA)
Beck Depression Inventory (BDI)
Body Mass Index (BMI)
Depression Anxiety, Stress Scale (DASS) questionnaire
High sensitivity C-Reactive Protein (Hs-CRP)
Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire
Omega-3 Fatty Acids
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short Form (SF)
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Test
Total Cholesterol
University of Rhode Island Change Assessment (URICA) questionnaire
Waist Circumference (WC)
Waist to Hip Ratio (WHR)
Month 12
Beck Anxiety Inventory (BAI)
Hip Circumference (HC)
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Test

Trial Safety

Trial Design

0 Treatment Group

This trial requires 400 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline at 12 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly change from baseline at 12 months for reporting.

Closest Location

Personalized Lifestyle Medicine Center - Gig Harbor, WA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
male or female
ages 18-80, inclusive
willing to give written informed consent to participate in the study

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Autoimmune Diseases by sharing your contact details with the study coordinator.